AIM Health Group to raise $3.5 million through private placement

NewsGuard 100/100 Score

AIM Health Group Inc. ("AIM" or the "Company") (TSXV - AHG), a fully integrated health care company, announced today that it has engaged Raymond James Ltd., on a "commercially reasonable efforts" agency basis, to complete a private placement of up to $3.5 million principal amount of 10% convertible secured debentures (the "Debentures") to accredited investors.

The Debentures are to be priced at par per $1,000 principal amount thereof, bear interest at a rate of 10% per annum, payable quarterly, and mature three years from the date of closing of the private placement. The Debentures are to be convertible into common shares, at the option of the holder at any time prior to maturity, at a conversion price of $0.30 per share. The Company can redeem the Debentures at any time after one year, without penalty, and may force the conversion of the Debentures if the volume weighted average trading price of its common shares is at or above $0.40 for 20 calendar days.

AIM intends to use the net proceeds of the private placement to repay debt and for capital expansion purposes. The private placement is subject to, among other things, the completion of definitive documentation and regulatory approval.

Source:

AIM HEALTH GROUP INC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization